Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD
暂无分享,去创建一个
K. Morgan | J. Roca | W. MacNee | N. Kalsheker | V. Keatings | A. Millar | S. Donnelly | S. Monti | M. Miniati | P. Hiemstra | R. Rabinovich | S. Chappell | J. Stolk | L. Daly | C. O'connor | J. Lotya | L. Daly | T. Guetta‐Baranés | J. Roca | Tamar Guetta‐Baranés | W. Macnee | Vera M. Keatings
[1] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[2] P. Thompson,et al. Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt , 2007, Respirology.
[3] D. Deepak,et al. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. , 2007, Biochemical and biophysical research communications.
[4] B. Make,et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. , 2007, American journal of respiratory and critical care medicine.
[5] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[6] Bing Li,et al. Genetic analysis of CC16, OGG1 and GCLC polymorphisms and susceptibility to COPD , 2007, Respirology.
[7] M. Abramson,et al. Microsomal Epoxide Hydrolase Is Not Associated with COPD in a Community-Based Sample , 2006, Human biology.
[8] Jing Shao,et al. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. , 2006, American journal of respiratory and critical care medicine.
[9] A. Gulsvik,et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1 , 2006, European Respiratory Journal.
[10] K. Morgan,et al. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease , 2006, Human mutation.
[11] N. Laird,et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. , 2005, American journal of respiratory cell and molecular biology.
[12] Jong Y. Park,et al. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. , 2005, International journal of molecular medicine.
[13] R. Pauwels,et al. Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.
[14] D. Christiani,et al. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. , 2004, Chinese medical journal.
[15] D. Nebert,et al. Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse , 2002, The Journal of Biological Chemistry.
[16] Y. Soini,et al. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. , 2002, American journal of respiratory and critical care medicine.
[17] E. Silverman,et al. The genetics of chronic obstructive pulmonary disease , 2001, Respiratory research.
[18] N. Hizawa,et al. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. , 2000, The European respiratory journal.
[19] W. MacNee,et al. Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. , 2000, Free radical biology & medicine.
[20] V. Hosagrahara,et al. Epoxide hydrolase--polymorphism and role in toxicology. , 2000, Toxicology letters.
[21] J. Yim,et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1 , 2000, Thorax.
[22] 好川 基大. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese , 2000 .
[23] M. Yamakido,et al. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. , 2000, International journal of molecular medicine.
[24] W. MacNee,et al. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[25] P. Sham,et al. Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.
[26] C. Hassett,et al. Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. , 1998, Carcinogenesis.
[27] D. Harrison,et al. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.
[28] C. J. Omiecinski,et al. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.
[29] Y. B. Cho,et al. Interpretation of Bronchodilator Response inPatients with Obstructive Airway Disease , 1995 .
[30] J. S. Sidhu,et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.